USA Financial Formulas’s Teradyne TER Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$952K Buy
2,375
+377
+19% +$139K 0.19% 37
2026
Q2
$967K Sell
1,998
-270
-12% -$102K 0.18% 35
2026
Q1
$672K Sell
2,268
-402
-15% -$112K 0.13% 57
2025
Q4
$517K Buy
+2,670
New +$458K 0.09% 80
2021
Q1
– Sell
-2,540
Closed -$305K – 429
2020
Q4
$305K Buy
+2,540
New +$259K 0.24% 100
2018
Q1
– Sell
-12,008
Closed -$503K – 406
2017
Q4
$503K Buy
+12,008
New +$495K 0.12% 145
2017
Q3
– Sell
-22,410
Closed -$673K – 323
2017
Q2
$673K Sell
22,410
-3,111
-12% -$105K 0.16% 130
2017
Q1
$794K Buy
+25,521
New +$730K 0.19% 108

Other funds holding TER

USA Financial Formulas's TER Position: Q3 2026 in Review

USA Financial Formulas increased its Teradyne (TER) stake by 19% in Q3 2026, buying an estimated $139K and bringing the position to 2,375 shares worth $952K. The position accounts for 0.19% of the portfolio, ranked #37.

USA Financial Formulas first reported a position in TER in Q1 2017 and has held it in 8 quarters since. The position peaked at $967K in Q2 2026. 364 funds tracked by Wall St. Rank hold TER as of Q3 2026.

  • USA Financial Formulas held 2,375 shares of Teradyne worth $952K as of Q3 2026.
  • USA Financial Formulas bought 377 Teradyne shares in Q3 2026, an estimated $139K.
  • Teradyne made up 0.19% of USA Financial Formulas's portfolio in Q3 2026, its #37 holding.
  • USA Financial Formulas first reported a position in Teradyne in Q1 2017 and has held it in 8 quarters since.
  • USA Financial Formulas's Teradyne position peaked at $967K in Q2 2026.
  • 364 funds tracked by Wall St. Rank held Teradyne as of Q3 2026.

Based on USA Financial Formulas's 13F filing for Q3 2026, filed 16 Oct 2026.